BeStock  
Stocks › Biotechnology › CLYM

Climb Bio CLYM

US equityMarket cap rank #3548Biotechnology
$9.19 −$0.09 (-0.97%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.03 -1.76%
Open$8.98
Prev close$9.28
Day range$8.90 – $9.40
Volume770.2K
Market cap$539.80M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership128.8%+21.37 pts vs. prior quarter
Institutions holding150+21 vs. prior quarter
Insider trades (recent)38 buys / 11 sellsNet buying
Short interest18.48% of floatDays to cover 7.8 · as of 30 Oct 2026
Short-sale volume share27.6%5-day average of daily volume

Short-sale volume as % of daily volume

9%19%29%40%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$7.02M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$7.4MSuper+$419.1KBig+$264.7KMid−$115.1KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 59.0% of shares outstanding.

Largest holders

  • RA Capital Management, L.P.21.47%
  • FMR15.78%
  • Pontifax Venture Capital8.86%
  • UBS Asset Management7.64%
  • Deerfield Management Company, L.P.5.23%
  • BlackRock5.00%
  • Braidwell LP4.76%
  • Adage Capital Management, L.P.4.27%

By investor type

  • Mutual Fund56.48%
  • Hedge Fund34.64%
  • VC/PE Fund33.96%
  • Public Company2.71%
  • Individual/Insider1.62%
  • Private Company0.74%
  • Insurance Company0.13%
  • Government Pension Fund0.08%

Reported short interest has risen from 13.16% to 18.48% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
RA Capital Management, L.P. VC/PE Fund 2026/Q3 +1,309,063 21.5%
Deerfield Management Company, L.P. Hedge Fund 2026/Q3 +3,070,000 5.2%
FMR Mutual Fund 2026/Q3 +2,478,697 15.8%
State Street Global Advisors Mutual Fund 2026/Q3 +1,163,238 3.1%
UBS Asset Management Mutual Fund 2026/Q3 +1,084,593 7.6%
Morgan Stanley Public Company 2026/Q3 +755,346 1.9%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +755,346 1.9%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +677,279 4.0%
BlackRock Mutual Fund 2026/Q3 +582,044 5.0%
RA Capital Management, L.P. VC/PE Fund 2026/Q3 +1,239,063 21.8%
Stephen Thomas Individual/Insider 2026/Q3 +313,312 0.8%
FMR Mutual Fund 2026/Q3 +6,783,967 11.8%
UBS Asset Management Mutual Fund 2026/Q3 +3,318,921 5.9%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +2,506,000 4.3%
Cormorant Asset Management, LP Hedge Fund 2026/Q3 +2,106,000 3.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
27 Sep 2026 Andrew Levin Former Director Derivative Exercise and Retained +70,000 $7.89 70,000
14 Sep 2026 Stephen Thomas Director Automatic Disposition -100,000 $13.67 467,969
28 Jun 2026 RA Capital Management, L.P. Other Derivative Acquisition +70,284 $13.36 70,284
28 Jun 2026 Aoife Brennan Chief Executive Officer Intent to Sell (Form 144) -30,902 $13.17 –
28 Jun 2026 Aoife Brennan Chief Executive Officer Derivative Exercise and Sale -30,902 $13.17 87,731
26 Jun 2026 Aoife Brennan Chief Executive Officer Derivative Exercise and Retained +37,848 – 87,731
4 Jun 2026 Douglas Williams Independent Chairperson Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 Kimberlee Drapkin Independent Director Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 RA Capital Management, L.P. Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 Andrew Levin Former Director Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 Alexander Cumbo Independent Director Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 Stephen Thomas Director Other Derivative Acquisition +40,000 $10.55 40,000
4 Jun 2026 Judith Dunn Independent Director Other Derivative Acquisition +40,000 $10.55 40,000
28 Apr 2026 RA Capital Management, L.P. Other Derivative Acquisition +2,106,000 $0.00 22,546,000
25 Feb 2026 Stephen Thomas Director Automatic Disposition -50,000 $7.01 154,657
24 Feb 2026 Stephen Thomas Director Intent to Sell (Form 144) -50,000 $6.36 –
12 Feb 2026 Stephen Thomas Director Automatic Disposition -100,000 $5.81 204,657
11 Feb 2026 Stephen Thomas Director Intent to Sell (Form 144) -100,000 $5.56 –
5 Jan 2026 Cindy Driscoll Former Senior VP of Finance & Principal Accounting Officer Other Derivative Acquisition +100,000 $3.81 100,000
5 Jan 2026 Aoife Brennan Chief Executive Officer Other Derivative Acquisition +700,000 $3.81 700,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 10,614,602 18.5% 7.8
15 Oct 2026 9,787,492 17.0% 10.3
30 Sep 2026 9,718,558 16.9% 5.6
15 Sep 2026 8,508,354 14.8% 4.5
31 Aug 2026 7,300,939 12.7% 5.9
14 Aug 2026 7,557,264 13.2% 6.3

Discussion

No comments yet — be the first to weigh in on CLYM.

Sign in to join the discussion.

Scroll to Top